Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
JieGuQiLi Capsule is a Traditional Chinese Medicine (TCM) formulation used to promote bone healing and alleviate pain associated with fractures and soft tissue injuries. It is a multi-ingredient herbal product typically containing components such as Panax notoginseng (Sanqi), Drynaria fortunei (Gusuibu), and other traditional herbs known for their ability to invigorate blood circulation, resolve blood stasis, and strengthen bone tissue. The drug is commonly indicated for the treatment of distal radius fractures and other orthopedic conditions. It is currently being studied in prospective, multicenter, randomized controlled trials to establish high-quality evidence for its therapeutic efficacy in fracture management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jiegu qili capsule.